NCT04909632

Brief Summary

This study is a prospective cross-sectional study. The investigators enroll participants form the department of endocrinology and of metabolism, China Medical University Hospital. In total, 300 participants , composed of 100 of type 2 diabetes , 100 of pre-DM and 100 healthy participants. The investigators apply tongue diagnosis system, pulse wave analysis, body constitution questionnaires, and nailfold capillaroscopy to assess the differences of TCM diagnosis. After collecting the tongue coating and analyzing the metabolite signals with a flying mass spectrometer, The investigators collect the data to establish metabolite pattern and biomarkers. This study aims to identify the clinical symptoms of DM with TCM diagnostic tools and investigate the pattern difference and treatment for DM. Furtherly, the investigators add mass spectrometer to analyze the metabolites of tongue coating, the investigators propose to establish a metabolite pattern and biomarker to identify important biological indicators of DM.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P50-P75 for not_applicable diabetes-mellitus

Timeline
Completed

Started Mar 2020

Typical duration for not_applicable diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2020

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

May 22, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 2, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2022

Completed
Last Updated

April 3, 2025

Status Verified

March 1, 2025

Enrollment Period

1.8 years

First QC Date

May 22, 2021

Last Update Submit

March 31, 2025

Conditions

Keywords

diabetic mellitus , tongue fur, metabolites, and biomarkers

Outcome Measures

Primary Outcomes (1)

  • The differentiation of tongue features mellitus and pre-diabetes

    The primary outcome is the differentiation of tongue features extracted by ATDS. There are nine primary features for TCM clinical tongue diagnosis, namely, tongue shape, tongue color, fur thickness, fur color, saliva, tongue fissure, ecchymosis, teeth mark, and red dot. Features identified are further sub-divided according to the areas located, i.e., heart-lung area, left liver-gall, right liver-gall, spleen-stomach, and kidney.

    2 years

Secondary Outcomes (1)

  • The tongue coating metabolic markers in patients with diabetes

    2 years

Study Arms (1)

To establish metabolite pattern and biomarkers of tongue fur in DM

EXPERIMENTAL
Diagnostic Test: Liquid chromatography-mass spectrometry (LC-MS) analysis

Interventions

The data were acquired by UNIFI software (Waters) and processed by UNIFI and Progenesis QI software. Omics analysis methods, such as principal component analysis (PCA), partial least squares-discriminate analysis (PLS-DA), and orthogonal partial least squares-discriminate analysis (OPLS-DA), were employed to identify the biochemical patterns in tongue coating samples and suggest variables that can be used as biomarkers for diabetes and pre-diabetes.

To establish metabolite pattern and biomarkers of tongue fur in DM

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of type 2 DM
  • Clinical diagnosis of pre-DM
  • Participants in the control group had a normal fasting glucose level

You may not qualify if:

  • comorbidity of inadequate heart, liver, kidney, or other serious diseases.
  • pregnancy or lactation.
  • history of mental illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University Hospital

Taichung, 40402, Taiwan

Location

MeSH Terms

Conditions

Diabetes MellitusGlucose Intolerance

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHyperglycemia

Study Officials

  • Lun-Chien Lo

    China Medical University, China

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2021

First Posted

June 2, 2021

Study Start

March 1, 2020

Primary Completion

December 31, 2021

Study Completion

July 31, 2022

Last Updated

April 3, 2025

Record last verified: 2025-03

Locations